Akèy › Maladi zo
Etid klinik pou Maladi zo ap rekrite nan Etazini
11 etid pou Maladi zo ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Natural History Study of Bone and Mineral Disorders
Ap rekriteEtid obsèvasyon
1 Day – 100 Years · Tout sèks · Mizajou Sep 28, 2026 · NCT00024804Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia
Ap rekriteFaz 2/3
Laj 2 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT07441876A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT06525636Autologous Bone Marrow Aspirate Treatment for Early-Stage Osteonecrosis
Ap rekrite
Laj 18 a 90 · Tout sèks · Mizajou Sep 17, 2026 · NCT06123481Musculoskeletal Cancers Remote Monitoring and Care
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07129226A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle
Ap rekriteFaz 3
Laj 17 a 65 · Tout sèks · Mizajou Jul 23, 2026 · NCT06915233Prospective Clinical Assessment Study in Children With Hypochondroplasia
Ap rekriteEtid obsèvasyon
30 Months – 16 Years · Tout sèks · Mizajou Jul 16, 2026 · NCT06410976Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)
Ap rekriteFaz 2
0 Years – 32 Months · Tout sèks · Mizajou Jul 13, 2026 · NCT07169279Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 8, 2026 · NCT06863129Estrogen Supplementation and Bone Health in Women With CF
Ap rekriteFaz 4
Laj 0 a 100 · Fanm · Mizajou Nov 14, 2025 · NCT05704036Characterization of Familial Myopathy and Paget Disease of Bone
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 18, 2025 · NCT01166854Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.